The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

Akarachkova E.S.

Medical Institute of Peoples’ Friendship University

Dovgan E.V.

Smolensk Regional Clinical Hospital

Kotova O.V.

Medical Institute of Peoples’ Friendship University;
International Society for the Study of Stress «Stress under control»

Demidova T.Yu.

Pirogov Russian National Research Medical University

Klimenko A.A.

Pirogov Russian National Research Medical University

Kokorin V.A.

Pirogov Russian National Research Medical University

Ostroumova O.D.

Russian Medical Academy of Continuous Professional Education

Ostroumova T.M.

Sechenov First Moscow State Medical University (Sechenov University)

Management of patients with insomnia and polymorbidity: expert consensus

Authors:

Poluektov M.G., Akarachkova E.S., Dovgan E.V., Kotova O.V., Demidova T.Yu., Klimenko A.A., Kokorin V.A., Ostroumova O.D., Ostroumova T.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5‑2): 49‑57

DOI: 10.17116/jnevro202312305249

Read: 2534 times

Download PDF (RU)
Contact the author
Table of contents

MANAGEMENT OF PATIENTS WITH INSOMNIA AND POLYMORBIDITY: EXPERT CONSENSUS
MANAGEMENT OF PATIENTS WITH INSOMNIA AND POLYMORBIDITY: EXPERT CONSENSUS

To cite this article:

Poluektov MG, Akarachkova ES, Dovgan EV, et al. . Management of patients with insomnia and polymorbidity: expert consensus. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5‑2):49‑57. (In Russ.)
https://doi.org/10.17116/jnevro202312305249

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Inso­mnia in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):46-51
The role of astrocytes, circadian rhythms and light pollution in the pathogenesis of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):20-25
Central sensitization and como­rbid diso­rders in patients with coro­nary heart disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):89-93
Vali­dation of ballistocardiography data for predicting the sleep effi­ciency in healthy indi­viduals and patients with inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):60-66
Carbonyl stress in meno­pausal women with inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):192-197
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61
Sleep deprivation and the deve­lopment of oxidative stress in animal models. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):124-129
The state of mental health of migrant workers and citi­zens of the Russian Fede­ration: A comparative analysis as illu­strated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101

Sleep disorders are becoming increasingly important due to the high comorbidity with other diseases and a significant impact on the patient’s quality of life. Insomnia is the most common sleep disorder both in the general population and in patients with multimorbid pathology. Its prevalence in the general population is 6—15%, while in patients with somatic diseases it increases up to 20—40% and can reach 90% in patients with comorbid mental disorders. Another problem is the development of drug-induced insomnia. Insomnia has negative impact on the prognosis of comorbid diseases, including an increased risk of death, more severe disease, and a worse quality of life. The presence of sleep disorders makes it difficult to effectively treat the underlying disease, so it is extremely important to identify and correct these disorders in the early stages, therefore recommendations for the diagnosis of insomnia in polymorbid patients are proposed. Modern methods of treating acute and chronic insomnia and features of insomnia treatment in polymorbid patients are also discussed.

Keywords:

sleep
sleep disorders
insomnia
polymorbidity

Authors:

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

Akarachkova E.S.

Medical Institute of Peoples’ Friendship University

Dovgan E.V.

Smolensk Regional Clinical Hospital

Kotova O.V.

Medical Institute of Peoples’ Friendship University;
International Society for the Study of Stress «Stress under control»

Demidova T.Yu.

Pirogov Russian National Research Medical University

Klimenko A.A.

Pirogov Russian National Research Medical University

Kokorin V.A.

Pirogov Russian National Research Medical University

Ostroumova O.D.

Russian Medical Academy of Continuous Professional Education

Ostroumova T.M.

Sechenov First Moscow State Medical University (Sechenov University)

Received:

03.05.2023

Accepted:

10.05.2023

List of references:

  1. Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700.  https://doi.org/10.1111/jsr.12594
  2. The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic criteria for research. Geneva: World Health Organization; 1993.
  3. The international classification of sleep disorders, revised. 3rd ed. Darien, Il: American Academy of Sleep Medicine; 2014.
  4. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
  5. Nilsen KB, Bakke ØK, Goll JB, Hopstock LA. Sleep patterns and insomnia in a large population-based study of middle-aged and older adults: the Tromso study 2015—2016. J Sleep Res. 2021;30(1):e13095. https://doi.org/10.1111/jsr.13095
  6. Entrambasaguas M, Romero O, Guevara JAC, et al. The prevalence of insomnia in Spain: A stepwise addition of ICSD-3 diagnostic criteria and notes. Sleep Epidemiol. 2023;3:100053. https://doi.org/10.1016/j.sleepe.2022.100053
  7. Appleton SL, Reynolds AC, Gill TK, et al. Insomnia prevalence varies with symptom criteria used with implications for epidemiological studies: role of anthropometrics, sleep habit, and comorbidities. Nat Sci Sleep. 2022;14:775-790.  https://doi.org/10.2147/NSS.S359437
  8. Bochkarev MV, Korostovtseva LS, Filchenko IA, et al. Social-demographic aspects of insomnia in the Russian population according to ESSE-RF study. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(4-2):26-34. (In Russ.). https://doi.org/10.17116/jnevro20181184226
  9. Andreeva VA, Torres MJ, Druesne-Pecollo N, et al. Sex-specific associations of different anthropometric indices with acute and chronic insomnia. Eur J Public Health. 2017;27(6):1026-1031. https://doi.org/10.1093/eurpub/ckx123
  10. Levenson JC, Kay DB, Buysse DJ. The pathophysiology of insomnia. Chest. 2015;147(4):1179-1192. https://doi.org/10.1378/chest.14-1617
  11. Maust DT, Strominger J, Kim HM, et al. Prevalence of central nervous system-active polypharmacy among older adults with dementia in the US. JAMA. 2021;325(10):952-961.  https://doi.org/10.1001/jama.2021.1195
  12. Kalmbach DA, Cuamatzi-Castelan AS, Tonnu CV, et al. Hyperarousal and sleep reactivity in insomnia: current insights. Nat Sci Sleep. 2018;10:193-201.  https://doi.org/10.2147/NSS.S138823
  13. Vargas I, Nguyen AM, Muench A, et al. Acute and chronic insomnia: what has time and/or hyperarousal got to do with it? Brain Sci. 2020;10(2):71.  https://doi.org/10.3390/brainsci10020071
  14. Plante DT, Jensen JE, Schoerning L, Winkelman JW. Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder? Neuropsychopharmacology. 2012;37(6):1548-1557. https://doi.org/10.1038/npp.2012.4
  15. Altena E, Van Der Werf YD, Sanz-Arigita EJ, et al. Prefrontal hypoactivation and recovery in insomnia. Sleep. 2008;31(9):1271-1276. https://pubmed.ncbi.nlm.nih.gov/18788652/
  16. Baglioni C, Spiegelhalder K, Regen W, et al. Insomnia disorder is associated with increased amygdala reactivity to insomnia-related stimuli. Sleep. 2014;37(12):1907-1917. https://doi.org/10.5665/sleep.4240
  17. Li C, Liu Y, Yang N, et al. Functional connectivity disturbances of the locus coeruleus in chronic insomnia disorder. Nat Sci Sleep. 2022;14:1341-1350. https://doi.org/10.2147/NSS.S366234
  18. Kay DB, Buysse DJ. Hyperarousal and beyond: new insights to the pathophysiology of insomnia disorder through functional neuroimaging studies. Brain Sci. 2017;7(3):23.  https://doi.org/10.3390/brainsci7030023
  19. Khurshid KA. Comorbid insomnia and psychiatric disorders: an update. Innov Clin Neurosci. 2018;15(3-4):28-32.  https://pubmed.ncbi.nlm.nih.gov/29707424/
  20. Javaheri S, Redline S. Insomnia and risk of cardiovascular disease. Chest. 2017;152(2):435-444.  https://doi.org/10.1016/j.chest.2017.01.026
  21. Wang Q, Wang X, Yang C, Wang L. The role of sleep disorders in cardiovascular diseases: Culprit or accomplice? Life Sci. 2021;283:119851. https://doi.org/10.1016/j.lfs.2021.119851
  22. Ostroumova OD, Isaev RI, Pereverzev AP. Drug-induced insomnia in old and very old patients. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2019;119(8):142-152. (In Russ.). https://doi.org/10.17116/jnevro2019119081142
  23. Smith L, Shin JI, Jacob L, et al. Association between physical multimorbidity and sleep problems in 46 low- and middle-income countries. Maturitas. 2022;160:23-31.  https://doi.org/10.1016/j.maturitas.2022.01.007
  24. Gadermann AM, Alonso J, Vilagut G, et al. Comorbidity and disease burden in the National Comorbidity Survey Replication (NCS-R). Depress Anxiety. 2012;29(9):797-806.  https://doi.org/10.1002/da.21924
  25. Lima MG, Bergamo Francisco PM, de Azevedo Barros MB. Sleep duration pattern and chronic diseases in Brazilian adults (ISACAMP, 2008/09). Sleep Med. 2012;13(2):139-144.  https://doi.org/10.1016/j.sleep.2011.07.011
  26. Jarrin DC, Alvaro PK, Bouchard MA, et al. Insomnia and hypertension: A systematic review. Sleep Med Rev. 2018;41:3-38.  https://doi.org/10.1016/j.smrv.2018.02.003
  27. Liu D, Yu C, Huang K, et al. The association between hypertension and insomnia: a bidirectional meta-analysis of prospective cohort studies. Int J Hypertens. 2022;2022:4476905. https://doi.org/10.1155/2022/4476905
  28. Luyster FS, Strollo PJ Jr, Holguin F, et al. Association between insomnia and asthma burden in the Severe Asthma Research Program (SARP) III. Chest. 2016;150(6):1242-1250. https://doi.org/10.1016/j.chest.2016.09.020
  29. Sundbom F, Malinovschi A, Lindberg E, et al. Insomnia symptoms and asthma control-Interrelations and importance of comorbidities. Clin Exp Allergy. 2020;50(2):170-177.  https://doi.org/10.1111/cea.13517
  30. Al-Harbi A, Alanazi T, Alghamdi H, et al. Prevalence of insomnia among patients with bronchial asthma. J Asthma Allergy. 2022;15:111-116.  https://doi.org/10.2147/JAA.S345086
  31. Alanazi TM, Alghamdi HS, Alberreet MS, et al. The prevalence of sleep disturbance among asthmatic patients in a tertiary care center. Sci Rep. 2021;11(1):2457. https://doi.org/10.1038/s41598-020-79697-x
  32. Lin YC, Lai CC, Chien CC, et al. Is insomnia a risk factor for new-onset asthma? A population-based study in Taiwan. BMJ Open. 2017;7(11):e018714. https://doi.org/10.1136/bmjopen-2017-018714
  33. Louie GH, Tektonidou MG, Caban-Martinez AJ, Ward MM. Sleep disturbances in adults with arthritis: prevalence, mediators, and subgroups at greatest risk. Data from the 2007 National Health Interview Survey. Arthritis Care Res (Hoboken). 2011;63(2):247-260.  https://doi.org/10.1002/acr.20362
  34. Allen KD, Renner JB, DeVellis B, et al. Osteoarthritis and sleep: The Johnston County osteoarthritis project. J Rheumatol. 2008;35:1102-1107. https://pubmed.ncbi.nlm.nih.gov/18484690/
  35. Wilcox S, Brenes GA, Levine D, et al. Factors related to sleep disturbance in older adults experiencing knee pain or knee pain with radiographic evidence of knee osteoarthritis. J Am Geriatr Soc. 2000;48:1241-1251. https://doi.org/10.1111/j.1532-5415.2000.tb02597.x
  36. Cho Y, Jung B, Lee YJ, et al. Association between sleep duration and osteoarthritis and their prevalence in Koreans: A cross-sectional study. PLoS One. 2020;15(4):e0230481. https://doi.org/10.1371/journal.pone.0230481
  37. Kim J, Cho SJ, Kim WJ, et al. Impact of migraine on the clinical presentation of insomnia: a population-based study. J Headache Pain. 2018;19(1):86.  https://doi.org/10.1186/s10194-018-0916-5
  38. Kim J, Cho SJ, Kim WJ, et al. Insufficient sleep is prevalent among migraineurs: a population-based study. J Headache Pain. 2017;18(1):50.  https://doi.org/10.1186/s10194-017-0756-8
  39. Schütz L, Sixel-Döring F, Hermann W. Management of Sleep Disturbances in Parkinson’s Disease. J Parkinsons Dis. 2022;12(7):2029-2058.
  40. Ylikoski A, Martikainen K, Sieminski M, Partinen M. Parkinson’s disease and insomnia. Neurol Sci. 2015;36(11):2003-2010. https://doi.org/10.1007/s10072-015-2288-9
  41. Baylan S, Griffiths S, Grant N, et al. Incidence and prevalence of post-stroke insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2020;49:101222. https://doi.org/10.1016/j.smrv.2019.101222
  42. Chen YK, Lu JY, Mok VC, et al. Clinical and radiologic correlates of insomnia symptoms in ischemic stroke patients. Int J Geriatr Psych. 2011;26(5):451-457.  https://doi.org/10.1002/gps.2547
  43. Glozier N, Moullaali TJ, Sivertsen B, et al. The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study. Cerebrovasc Dis Extra. 2017;7(1):9-20.  https://doi.org/10.1159/000455751
  44. Ferre Navarrete F, Pérez Páramo M, Fermin Ordoño J, López Gómez V. Prevalence of Insomnia and Associated Factors in Outpatients With Generalized Anxiety Disorder Treated in Psychiatric Clinics. Behav Sleep Med. 2017;15(6):491-501.  https://doi.org/10.1080/15402002.2016.1163703
  45. Singareddy R, Uhde TW. Nocturnal sleep panic and depression: relationship to subjective sleep in panic disorder. J Affect Disord. 2009;112:262-266.  https://doi.org/10.1016/j.jad.2008.04.026
  46. Ahmadi R, Rahimi-Jafari S, Olfati M, et al. Insomnia and post-traumatic stress disorder: A meta-analysis on interrelated association (n=57,618) and prevalence (n=573,665). Neurosci Biobehav Rev. 2022;141:104850. https://doi.org/10.1016/j.neubiorev.2022.104850
  47. Park SC, Kim JM, Jun TY, et al. Prevalence and Clinical Correlates of Insomnia in Depressive Disorders: The CRESCEND Study. Psychiatry Investig. 2013;10(4):373-381.  https://doi.org/10.4306/pi.2013.10.4.373
  48. Li L, Wu C, Gan Y, et al. Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2016;16(1):375.  https://doi.org/10.1186/s12888-016-1075-3
  49. Ostroumova TM, Parfenov VA, Ostroumova OD, Kochetkov AI. Hypertension and insomnia. Therapeutic Archive. 2020;92(1):69-75. (In Russ.). https://doi.org/10.26442/00403660.2020.01.000319
  50. Kharaba Z, Feghali E, El Husseini F, et al. An Assessment of Quality of Life in Patients With Asthma Through Physical, Emotional, Social, and Occupational Aspects. A Cross-Sectional Study. Front Public Health. 2022;10:883784. https://doi.org/10.3389/fpubh.2022.883784
  51. Burgess HJ, Burns JW, Buvanendran A, et al. Associations Between Sleep Disturbance and Chronic Pain Intensity and Function: A Test of Direct and Indirect Pathways. Clin J Pain. 2019;35(7):569-576.  https://doi.org/10.1097/AJP.0000000000000711
  52. Evdokimova EM, Tabeeva GR. Insomnia in patients with migraine. Nevrologiya, Neiropsikhiatriya, Psikhosomatika. 2019;11(2):22-29. (In Russ.). https://doi.org/10.14412/2074-2711-2019-2-22-29
  53. Nodel MR, Yakhno NN, Ukraintseva YuV, Dorokhov VB. Insomnia in Parkinson’s disease and its impact on quality of life. Neurological Journal. 2014;19(4):19-27. (In Russ.). https://www.medlit.ru/journal/1187
  54. Wardle-Pinkston S, Slavish DC, Taylor DJ. Insomnia and cognitive performance: A systematic review and meta-analysis. Sleep Med Rev. 2019;48:101205. https://doi.org/10.1016/j.smrv.2019.07.008
  55. Li LJ, Yang Y, Guan BY, et al. Insomnia is associated with increased mortality in patients with first-ever stroke: a 6-year follow-up in a Chinese cohort study. Stroke Vasc Neurol. 2018;3(4):197-202.  https://dx.doi.org/10.1136/svn-2017-000136
  56. Rosenberg RP, Benca R, Doghramji P, Roth T. A 2023 Update on Managing Insomnia in Primary Care: Insights From an Expert Consensus Group. Prim Care Companion CNS Disord. 2023;25(1):22nr03385. https://doi.org/10.4088/PCC.22nr03385
  57. Poluektov MG, Buzunov RV, Averbukh VM, et al. Project of clinical recommendations on diagnosis and treatment of chronic insomnia in adults. Consilium Medicum. Neurology and Rheumatology. 2016;2:41-51. (In Russ.).
  58. Pchelina PV, Poluektov MG. Evolution of insomnia: transition from acute to chronic disorder. Meditsinskiy Sovet. 2020;(19):70-77. (In Russ.). https://doi.org/10.21518/2079-701X-2020-19-70-77
  59. Drover DR. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet. 2004;43(4):227-238.  https://doi.org/10.2165/00003088-200443040-00002
  60. Wade AG, Ford I, Crawford G, et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo-controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med. 2010;8(1):51. 
  61. Wang L, Pan Y, Ye C, et al. A network meta-analysis of the long- and short-term efficacy of sleep medicines in adults and older adults. Neurosci Biobehav Rev. 2021;131:489-496.  https://doi.org/10.1016/j.neubiorev.2021.09.035

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.